A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma

Condition:   Carcinoma, Renal Cell Interventions:   Drug: Spartalizumab;   Drug: Canakinumab Sponsors:   Charles G. Drake;   Novartis Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials